MENU
Achilles Therapeutics (ACHL) Ownership - Who owns Achilles Therapeutics?
Profile
Industry
N/A
Address
245 Hammersmith Road
Phone
+44 2081544600
Employees
242
Web
https://www.achillestx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.35M
P/E Ratio
N/A
Total Cash
95.11M
Projected Growth
N/A
Total Debt
4.46M
Revenue
N/A
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash/Share
2.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACHL
Capitalization
30.4M
P/E Ratio
N/A
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash
95.1M
Total Cash/Share
2.31
Total Debt
4.46M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
115M
P/B Ratio
0.25
Cash Flow
N/A
Earnings
-1.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
8.24
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-70.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-38.87
Shares Held By Institutions
18.9M
Shares Outstanding - Current
41.1M
Total Liabilities
15.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-20.045
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 Hammersmith Road
Phone
+44 2081544600
Employees
242
Web
https://www.achillestx.com